XtalPi Holdings Ltd
2228
Rang in Aktien
#4646
XtalPi Holdings Limited functions as an investment holding company, delivering... XtalPi Holdings Limited functions as an investment holding company, delivering sophisticated drug discovery and intelligent automation solutions across key markets including China, the United States, Europe, South Korea, and Japan. Its comprehensive drug discovery services encompass the entire research and development process, ranging from target validation and hit identification to lead generation, lead optimization, and PCC nomination. These services are adept across diverse therapeutic modalities, such as small molecules, antibodies, peptides, ADCs, and PROTACs. The company's intelligent automation solutions specifically utilize artificial intelligence and automation to facilitate the accelerated discovery and research of novel drugs and materials. Established in 2015 and based in Shenzhen, China, the firm was formerly known as QuantumPharm Inc. before officially changing its name to XtalPi Holdings Limited in December 2024.
Aktienkurs
$0.74616501
Marktkapitalisierung
$3.21B
Veränderung (1 Tag)
-4.10%
Veränderung (1 Jahr)
-50.36%
Land
CN
Handel XtalPi Holdings Ltd (2228)
Kategorie
Healthcare
P/B-Verhältnis für XtalPi Holdings Ltd (2228)
P/B-Verhältnis zum October 2026 TTM: 2.26
Laut den neuesten Finanzberichten und dem Aktienkurs von XtalPi Holdings Ltd beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 2.26. Am Ende des Jahres 2024 lag das P/B-Verhältnis bei 2.72.
P/B-Verlauf für XtalPi Holdings Ltd von 2024 bis 2026
P/B-Verhältnis zum Jahresende
| Jahr | P/B-Verhältnis | ändert |
|---|---|---|
| 2026 (TTM) | 2.26 | -33.91% |
| 2025 | 3.42 | 25.85% |
| 2024 | 2.72 | 0.00% |
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/B-Verhältnis | P/B-Verhältnis-Differenz | Land |
|---|---|---|---|
| 6.251 | 176.56% |
US
|
|
| 13.2547 | 486.41% |
US
|
|
| 4.4521 | 96.97% |
AU
|
|
| 6.3632 | 181.52% |
NL
|
|
| - | - |
CH
|
